Abstract. The present study assessed the expression of the DNA doublestrand repair (DDR) proteins ATM serine/threonine kinase (ATM), checkpoint kinase 2 (CHEK2) and γH2A histone family member X (γH2AFX) in oral leukoplakia (OL) and evaluated their clinical significance and usefulness as biomarkers for predicting OL transformation. Retrospectively, ATM, CHEK2 and γH2AFX protein levels were evaluated using immunohistochemical analysis in 61 OL, 33 oral squamous cell carcinoma (OSCC) and 15 normal oral mucosa tissues. OL tissues were classified into two groups according to the epithelial dysplasia pathology: The low risk dysplasia group (n=41) and the high-risk dysplasia group (n=20). The results of the present study revealed that the expression of ATM and γH2AFX in OSCC was significantly increased compared with that in OL with low-risk dysplasia and normal oral mucosa tissues. There was no statistically significant difference in CHEK2 expression among the groups. ATM expression was correlated with that of γH2AFX in OSCC tissue. The prognostic values of the DDR proteins and their correlation with clinical and pathological parameters were evaluated further in 99 OL patients with low risk dysplasia. Multivariate analysis revealed that increased expression of ATM and γH2AFX was significantly associated with an increased risk of malignant transformation. Immunohistochemical analysis of ATM and γH2AFX protein expression provided useful prognostic information on the carcinogenesis of OL. Increased ATM and γH2AFX expression may indicate a poor prognosis.
Introduction
Oral cavity cancer is the most common head and neck cancer (1) . It was estimated that 300,400 new cases of oral cavity cancer and 145,400 cases of oral cavity cancer-induced mortality have occurred in 2012 globally (2) . Oral leukoplakia (OL) is one of the most common potentially malignant disorders of the oral cavity (3), with a malignant transformation rate of 17-35% (4) . The prognosis and overall survival rate of patients with oral cavity cancer depend on the early detection of any lesion that may identify a patient with increased risk or with early infiltration prior to metastatic disease (3) .
DNA doublestrand repair (DDR) is associated with cancer occurrence and progression (5, 6) . DDR activation occurs almost universally in the earliest stages of carcinogenesis (7, 8) . Three DDR proteins, ATM serine/threonine kinase (ATM), checkpoint kinase 2 (CHEK2) and γH2AFX have been observed in numerous premalignant lesions and are associated with the DNA damage response (7, (9) (10) (11) .
ATM activates checkpoint signaling at doublestrand breaks (DSBs), following apoptosis and in response to genotoxic stresses, and thereby functions as a DNA damage sensor. ATM responds to DSBs by phosphorylating numerous substrates and may initiate DSB signaling (12) .
CHEK2 is a crucial downstream target of ATM (13) . Following DNA damage, ATM preferentially activates CHEK2 (14) . Subsequently, activated CHEK2 modulates the activity of cell division cycle 25C, which either facilitates DNA repair or directs the cell to the apoptotic pathway (15, 16) . The expression of CHEK2 is aberrant in numerous human premalignant and malignant lesions (8, 17, 18) .
H2A histone family member X (H2AFX) is a key DDR component. Within minutes of DNA damage, H2AFX is phosphorylated at its carboxyl terminus to form γH2AFX at DSB sites (19) . The formation of numerous DDR proteins requires H2AFX, indicating that H2AFX serves a key function in the early stages of DDR. H2AFX protein is phosphorylated by ATM, and the level of γH2AFX is positively associated with the degree of DNA damage (20) .
Accordingly, the present study hypothesized that alterations to ATM, CHEK2 and γH2AFX may influence the carcinogenesis of OL. As the epithelium of OL is a useful model for monitoring abnormalities and exploring oral carcinogenesis (9), the present study evaluated the protein expression of ATM, CHEK2 and γH2AFX in OL and OSCC tissues using immunohistochemistry. In addition, the present study assessed the association between the clinicopathological data and expression of these proteins, and their usefulness as biomarkers for predicting the oral carcinogenesis. in a doubleblind manner and a consensus was reached in cases of discrepancy. Cell nuclear and/or cytoplasmic immunoreactivity in the epithelium was considered to indicate positive expression of ATM. Cell nuclear immunoreactivity in the epithelium was considered to indicate positive expression of CHEK2 and γH2AFX. Positive controls for the antibodies were used according to the manufacturer's instructions. Negative control slides omitted primary antibodies. Positive staining intensity was defined as 0, 1, 2, and 3 for no staining, light yellow, yellow brown, and brown, respectively. The scoring method used for ATM and γH2AFX was referred to by Hu et al (22) . The positive cell percentages of 0, 1-25, 26-50, 51-75, and >75 were defined as 0, 1, 2, 3, and 4, respectively. The scoring method used for CHEK2 was a modified version of that used by Alkema et al (23) . The positive cell percentages of 0-5, 6-25, 26-50, 51-75, and >75 were defined as 0, 1, 2, 3, and 4, respectively. The semiquantitative expression level was evaluated by multiplying the distribution and intensity score. A final score of <5 was defined as low expression of ATM and γH2AFX, of ≥5 as high expression of ATM and γH2AFX, of <7 as low expression of CHEK2, and of ≥7 as high expression of CHEK2.
Patients and methods

Patients
Statistical analysis. The SPSS 19.0 software package (IBM Corp., Armonk, NY, USA) was used for all statistical analysis. ATM, CHEK2 and γH2AFX expression levels in the normal tissue, OL low risk, OL high risk, and OSCC groups were compared using the Kruskal-Wallis test followed by Dunn's Test. The association between the expression of the proteins and clinicopathological features were assessed using a χ 2 test. Pearson correlation analysis was used to evaluate the association between protein expressions for patients in cohort 1. The Fisher's exact test was used to assess the statistical difference between the expression levels of certain proteins in cohort 2. A logistic regression model was used to evaluate the relative risk of OL malignant transformation. Ranked data were presented as percentage. All tests were two-sided. P<0.05 was considered to indicate a statistically significant difference.
Results
ATM, CHEK2 and γH2AFX expression levels in cohort 1.
ATM was primarily expressed in the nucleus and cytoplasm in the epithelium, while CHEK2 and γH2AFX were primarily expressed in the nucleus. Cells positive for ATM, CHEK2 and γH2AFX expression were detected not only in the stratum basale and stratum spinosum, but also in the stratum granulosum, and in the stratum corneum of certain patients (Fig. 1) . ATM expression tended to increase gradually in the normal tissue, OL low risk, OL high risk and OSCC groups during carcinogenesis (P=0.005; Table II) . ATM expression was significantly increased in 29/33 of the samples of the OSCC group, compared with the normal tissue group (P=0.008). In addition, ATM expression was significantly increased in 23/41 of the samples of the OL low risk group compared with the OSCC group (P=0.027). In the OL high-risk group, ATM expression in 13/20 of the samples exhibited no statistically significant difference compared with that in the other three groups, respectively. γH2AFX expression increased in the groups as carcinogenesis progressed (P=0.001; Table II) . A comparison of the groups revealed that there was a significant difference between the OL low risk and the OSCC groups (P=0.014), and between the normal tissue and the OSCC groups in γH2AFX expression (P= 0.001). There was no significant difference in CHEK2 expression among the four groups (P=0.074; Table II Fig. 2 ).
High expression of ATM as an independent factor for OL malignant transformation in cohort 2.
To evaluate the risk of OL malignant transformation, clinicopathological parameters, and ATM and γH2AFX expression were assessed using logistic regression ( 
Discussion
To the best of our knowledge, the present study is the first to evaluate ATM, CHEK2 and γH2AFX expression in patients with OL with multiple degrees of epithelial dysplasia and to assess the functions of these proteins in predicting the risk of OSCC in two independent cohorts using immunohistochemical analysis. ATM serves a key function in the DNA Non-tongue denotes buccal, gingiva, palate, mouth floor, or lip. ATM, ATM serine/threonine kinase; n, number of patients; OL, oral leukoplakia; OSCC, oral squamous cell carcinoma.
DSB-induced signaling cascade. Tumorigenic events that occur early in the progression of major types of human cancer activate ATM-regulated cell cycle checkpoints and thereby an inducible barrier that inhibits tumor progression and genetic instability (7, 24) . A previous study has demonstrated that ATM expression was increased in certain types of cancer tissue compared with that in benign tumorous lesions and normal tissues (22) . Other previous studies have suggested that ATM potentially represents a promising indicator for hyperplasia and cancer, and may serve as a useful marker for identifying patients with poor prognosis (25, 26) . Raynaud et al (10) demonstrated that the difference in ATM activation between normal and precancerous tissues was not significant, though ATM expression differed significantly between precancerous and cancerous tissues. The results of the aforementioned studies support those of the present study.
He et al (9) indicated that ATM protein expression was higher in OL compared with that in normal oral tissue, but demonstrated no significant difference between OL and OSCC tissues in ATM protein expression. The present study dynamically observed the activation of the DNA damage signaling pathway in normal oral mucosa, OL (low risk dysplasia and high risk dysplasia) and OSCC tissues in a large population. In contrast to the results demonstrated by He et al (9) those demonstrated in the present study revealed that ATM expression gradually increased as OL progressed to OSCC. In addition, the present study revealed a significant difference in ATM expression between OL with low risk dysplasia and OSCC. In the present study, ATM expression correlated with the degree of epithelial dysplasia during carcinogenesis and age, sex, lesion site, dietary habits, smoking history, and alcohol use were not significant factors in the expression of ATM. Therefore, the results of the present study indicated that ATM was activated in oral precancerous lesions and served a function in the early stages of oral carcinogenesis.
One of the proteins phosphorylated following DNA damage, a process initiated by ATM, is H2AFX, which, in phosphorylated form (γH2AFX), functions as a specific indicator for the presence of DSBs (27) . Increased γH2AFX expression may result in increased radiosensitivity (28) . Multiple studies have revealed that γH2AFX expression is increased in certain types of cancer and their premalignant lesions (8, 22, 29, 30) , which supports the results of the present study. Overexpression of γH2AFX may represent an independent prognostic indicator of a poor overall patient survival rate (31, 32) . In contrast to the results of the present study, Chou et al (33) reported that γH2AFX expression was increased in dysplastic epithelium and significantly decreased in OSCC tissue. The results of the present study revealed that γH2AFX expression increased in OSCC tissue with increasing disease severity; this discrepancy between the aforementioned and present study may be due to the difference in the OSCC tumor differentiation grade selected. In the present study, similar to ATM expression, γH2AFX expression correlated with the degree of epithelial dysplasia, according to the results of the associations between clinicopathological features and γH2AFX expression. Detecting γH2AFX expression may help to evaluate precancerous oral cavity lesions and monitor cancer progression. CHEK2 serves a key function in inhibiting cell cycle progression in response to the DNA damage pathway (34) . In multiple types of solid tumor, CHEK2 expression was decreased compared with that in normal tissues (35) (36) (37) . CHEK2 expression in oral precancerous lesions is rarely assessed. In the present study, the expression of CHEK2 protein altered during oral carcinogenesis. There were no significant differences between any two groups of the four during carcinogenesis. Based on these conflicting results, the present study suggested that: (I) Aberrant CHEK2 protein may be functionally defective and regulated by other, unknown upstream proteins during DDR; (II) CHEK2 protein expression is regulated differently depending on the type of carcinoma; (III) the ATM-CHEK2 pathway may not be associated with oral carcinoma or precancerous lesions or (IV) more complex signaling pathways may participate in the DNA damage response.
Pearson correlation analysis of cohort 1 demonstrated that γH2AFX and ATM expression was correlated (P=0.045; r=0.192), particularly in OSCC tissue (P=0.028; r=0.383). Therefore, the present study suggested that the ATM-γH2AFX pathway contributes to the DNA damage response.
For cohort 2, the present study assessed the prognostic value of ATM and γH2AFX expression and evaluate whether the prognostic value was independent of clinicopathological factors. Univariate and multivariate analysis revealed that increased ATM and γH2AFX expression was significantly associated with an increased risk of transformation (P<0.05).
The results of the present study indicated that increased ATM and γH2AFX expression served as an independent predictor of carcinogenesis. However, age, sex, lesion site, dietary habits, smoking history, and alcohol use were not revealed to be significant risk factors for OL malignant transformation in the cohort 2, a result that reflects that of multiple previous studies (38) (39) (40) .
To conclude, the results of the present study suggested that ATM and γH2AFX expression in OL tissue was associated with oral cancer progression. Immunohistochemical staining of ATM and γH2AFX may represent a promising technique for the early identification and risk evaluation of OSCC in patients with precancerous oral lesions. Further studies are required to assess the function of ATM and γH2AFX in oral carcinogenesis, including for grade I, II and III OSCC. Further study of the mechanisms underlying DNA damage and response in OL tissue is also required.
